에 대한 최신 뉴스 Lottery.com (NASDAQ:LTRY) 주식

Lottery.com

Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

Lottery.com Inc

Rosenblatt analyst Catharine Trebnick maintains Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) with a Buy and raises the price target from $115 to $125.

News

Price Target

Analyst Ratings

FTNT

Rosenblatt Maintains Buy on Fortinet, Raises Price Target to $125

HC Wainwright &amp; Co. analyst Mike Colonnese reiterates Cleanspark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) with a Buy and maintains $27 price target.

Reiteration

CLSK

HC Wainwright & Co. Reiterates Buy on Cleanspark, Maintains $27 Price Target

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">103.6500</td>
<td align="right">0.69</td>
<td align="right">0.67</td>
<td>352</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">88.7400</td>
<td align="right">0.17</td>
<td align="right">0.19</td>
<td>12.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">137.9900</td>
<td align="right">0.25</td>
<td align="right">0.18</td>
<td>311</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">235.2700</td>
<td align="right">0.44</td>
<td align="right">0.18</td>
<td>3.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">89.5399</td>
<td align="right">0.16</td>
<td align="right">0.17</td>
<td>177</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">52.1800</td>
<td align="right">0.07</td>
<td align="right">0.13</td>
<td>152.1K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">228.74</td>
<td align="right">-1.34</td>
<td align="right">-0.59</td>
<td>4.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">78.22</td>
<td align="right">-0.08</td>
<td align="right">-0.11</td>
<td>348</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">79.42</td>
<td align="right">-0.05</td>
<td align="right">-0.07</td>
<td>331</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">147.07</td>
<td align="right">-0.05</td>
<td align="right">-0.04</td>
<td>2.2K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

ETFs

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For February 7, 2025

Biotech

Contracts

General

DRIO

DarioHealth Enters Agreement With Blue Cross Blue Shield, Expanding AI-Driven Cardiometabolic Solutions For Diabetes, Hypertension, Weight Management

CYTH

Cyclo Therapeutics Presents Preliminary Data From Phase 3 TransportNPC Study Of Trappsol With 6 Of 7 Patients Showing Stabilization Or Improvement In Clinical Global Impression Over 48 Weeks; Topline 48-Week Interim Data Expected in H1 2025

Needham analyst Quinn Bolton maintains Monolithic Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) with a Buy and raises the price target from $600 to $800.

MPWR

Needham Maintains Buy on Monolithic Power Systems, Raises Price Target to $800

Guidance

BYRN

Byrna Says Well-Positioned To Generate Additional Cash And Expand Profitability In 2025 And Beyond

Needham analyst Quinn Bolton maintains Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) with a Buy and lowers the price target from $85 to $60.

MCHP

Needham Maintains Buy on Microchip Technology, Lowers Price Target to $60

Byrna Expects Strong YoY Growth As It Continues Executing Strategic Initiatives, While Q1 Historically Experiences Seasonal Slowdown In Consumer Spending

Byrna Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYRN#NASDAQ">BYRN</a>) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.10 by 310 percent.&nbsp;

Earnings

Earnings Beats

Earnings Misses

Byrna Technologies Q4 2024 GAAP EPS $0.41 Beats $0.10 Estimate

Northland Capital Markets analyst Greg Gibas maintains A-Mark Precious Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRK#NASDAQ">AMRK</a>) with a Market Perform and lowers the price target from $40 to $36.

AMRK

Northland Capital Markets Maintains Market Perform on A-Mark Precious Metals, Lowers Price Target to $36

ENFY

Enlightify Enters Cooperation Agreement With Huadian Gaintime Investment Fund Management Co. To Jointly Develop And Invest In Renewable Energy Projects

Frontier Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULCC#NASDAQ">ULCC</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.12 by 91.67 percent. The company reported quarterly sales of $1.002 billion which beat the analyst consensus estimate of $984.071 million by 1.82 percent. This is a 12.46 percent increase over sales of $891.000 million the same period last year.

ULCC

Frontier Group Holdings Q4 2024 Adj. EPS $0.23 Beats $0.12 Estimate, Sales $1.002B Beat $984.071M Estimate

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Protagonist Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTGX#NASDAQ">PTGX</a>) with a Buy and maintains $50 price target.

PTGX

HC Wainwright & Co. Reiterates Buy on Protagonist Therapeutics, Maintains $50 Price Target

Palatin Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ptn#NYSE">PTN</a>) ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that it has entered into definitive agreements with a single healthcare focused institutional investor for the purchase and sale of 4,688,000 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering (the "Registered Direct Offering") at a purchase price of $1.00 per share.

Penny Stocks

Offerings

Palatin Technologies Announces $4.7M Direct Offering Of 4.688M Shares Of Common Stock At A Price Of $1.00 Each

Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, which will focus on developing personalized software dashboards to enhance efficiency, decision-making, and operational agility of its current and future portfolio &nbsp;
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 07, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=4YyVFRqflcXwGqhUPTu2VjFDGgtLwrW5VTXaIRFyk-IIIPuNlzUJ1jQBS1XGZkeW2u04U49EFMJDxbmDv53lI7G3RQd22H4wFDcieWxEMMdgqIbb8q9NPbI8fnx3Mbk4">Conduit Pharmaceuticals Inc. </a>(Nasdaq: <a href="https://www.globenewswire.com/Tracker?data=ZTbTPPHxjU9RAGWKZNAxD9OEmTHgwAmSW93ya-3jDGJAoT_s17QSwtV023t8itckPH1PGyypdAhJgLcMBCOkJaQcs-63P0X8YmDPgL0iXJx3xZdGfHDatM_nKDvGX7dz7Ku1_yv2_IHuKXXf6ohNgLeoc5JQt7gupWXvm-x_9eb7n5iuRdTxyAAS0XEs3neoudqFzXxh_jB7kprIFCx9LQ4deVpkjll0AX-SQ0a7U-aMQzK0jJ0jkiPTYYdvTnPy">CDT)</a> ("Conduit" or the "Company"), today announces the successful completion of all milestones in Phase I of its strategic collaboration with Sarborg Limited. This transition to Phase II marks a positive step forward in Conduit's strategy to explore the integration advanced artificial intelligence (AI) and cybernetics into its drug development processes. With Phase I now complete, the Company is pleased to transition to Phase II, which will focus on the creation of personalized software dashboards to enhance operational efficiency and reporting.
The focus of Phase I was to establish a strong foundation for the collaboration with Sarborg, identify key inputs for the algorithmic approach, and align Sarborg's services with Conduit's strategic goals. The collaboration, initiated in December 2024, aims to revolutionize drug development by leveraging cutting-edge AI technologies to streamline drug repurposing, accelerate discovery, optimize solid-form identification, and enhance clinical trial monitoring. Phase I included teach-in sessions with management, the validation of Conduit's proprietary inputs that are critical for Sarborg's cybernetic models and, thirdly, a comprehensive market analysis of cocrystal candidates.
Conduit and Sarborg worked closely to align AI-driven processes with Conduit's portfolio needs, ensuring that proprietary inputs were tailored to maximize the potential of key assets, including AZD1656, AZD5904, AZD5658, CDT1656, and the AZD1656 cocrystals. Additionally, an in-depth market analysis of cocrystal candidates provided actionable insights into the competitive landscape, patent positioning, and market opportunities.
Conduit is now transitioning to Phase II, which is expected to focus on building the technological infrastructure necessary to support AI-driven drug development of its current and future portfolio of products. A key deliverable of this phase will be the creation of personalized software dashboards, designed to provide Conduit's key personnel with real-time access to critical data related to clinical trials, drug discovery, and portfolio management. These dashboards are designed to enable more agile and informed decision-making, allowing the Company to remain focused on delivering impactful clinical trials in autoimmune disorders.

Conduit Pharmaceuticals Transitions To Phase II In Sarborg Collaboration For AI-Driven Drug Development; Phase II To Focus On Personalized Software Dashboards To Enhance Efficiency And Decision-Making

Northland Capital Markets analyst Tim Savageaux maintains Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) with a Market Perform and raises the price target from $60 to $70.

LITE

Northland Capital Markets Maintains Market Perform on Lumentum Holdings, Raises Price Target to $70

GAN Announces Extension Of End Date Of SEGA SAMMY Merger Agreement From Feb. 7 To May 31

Rosenblatt analyst Barton Crockett maintains Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) with a Buy and raises the price target from $46 to $51.

PINS

Rosenblatt Maintains Buy on Pinterest, Raises Price Target to $51

FTEL

Fitell Announces $10M Registered Direct Offering Of 1,992,032 Shares And Warrants At $5.02 Each, Closing Expected By February 10, 2025

Lottery.com, Inc. (LTRY) has shared an announcement. Warren Macal, with over 15 years of wealth management experience, has been appointed to Lotter...

Lottery.com Appoints Wealth Expert After $18M Investment

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Lottery.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/ltry-stock-quote/">LTRY</a>) just reported results for the first quarter of 2024.<ul><li>Lottery.com reported earnings per share of -$1.99.</li><li>The company reported revenue of $259,319.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/ltry-stock-earnings-lottery-com-for-q1-of-2024/">LTRY Stock Earnings: Lottery.com Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

LTRY Stock Earnings: Lottery.com Reported Results for Q1 2024

Lottery.com, Inc. (LTRY) has provided an update. Mark Bernard Battles has announced his resignation from the Board of Directors of Lottery.com Inc....

Lottery.com Board Member Announces Amicable Resignation

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the trading week with a breakdown of the biggest pre-market stock movers worth reading about on Monday!



Moving stocks are the assassination attempt on former President Donald Trump, new agreements and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>DatChat (NASDAQ:<a href="https://investorplace.com/stock-quotes/dats-stock-quote/">DATS</a>) stock is rocketing more than 122% following <a href="https://www.cnn.com/politics/live-news/trump-rally-shooting-07-14-24/index.html">the assassination attempt</a> on former President Donald Trump.</li>



<li>Trump Media &amp; Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>) shares are soaring over 56% after the assassination attempt on the former President.</li>



<li>Phunware (NASDAQ:<a href="https://investorplace.com/stock-quotes/phun-stock-quote/">PHUN</a>) stock is surging more than 43% for those same reasons.</li>



<li>Pop Culture (NASDAQ:<a href="https://investorplace.com/stock-quotes/cpop-stock-quote/">CPOP</a>) shares are rising close to 38% alongside heavy pre-market trading.</li>



<li>Vince (NYSE:<a href="https://investorplace.com/stock-quotes/vnce-stock-quote/">VNCE</a>) stock is increasing over 23% without any news to report this morning.</li>



<li>Crown LNG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) shares are heading more than 18% higher with strong early morning trading today.</li>



<li>Valkyrie Bitcoin Futures Leveraged Strategy ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/btfx-stock-quote/">BTFX</a>) stock is climbing over 18% alongside a Bitcoin (<a href="https://investorplace.com/cryptocurrency/btc-usd/">BTC-USD</a>) rally</li>



<li>ProShares Trust ProShares Ultra Bitcoin ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/bitu-stock-quote/">BITU</a>) shares are gaining more than 17% for the same reason.</li>



<li>Universe Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/upc-stock-quote/">UPC</a>) stock is jumping over 15% without any clear news this morning.</li>



<li>ProShares Trust ProShares Ultra Ether ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/etht-stock-quote/">ETHT</a>) shares are up nearly 15% with a crypto rally.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Gamer Pakistan (NASDAQ:<a href="https://investorplace.com/stock-quotes/gpak-stock-quote/">GPAK</a>) stock is diving more than 25% without any clear news to report on Monday morning.</li>



<li>Qualigen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/qlgn-stock-quote/">QLGN</a>) shares are tumbling over 23% <a href="https://investorplace.com/2024/07/why-is-qualigen-qlgn-stock-up-141-today/">after a recent rally</a>.</li>



<li>TDH (NASDAQ:<a href="https://investorplace.com/stock-quotes/petz-stock-quote/">PETZ</a>) stock is taking a more than 21% beating after a Friday rally.</li>



<li>Eastside Distilling (NASDAQ:<a href="https://investorplace.com/stock-quotes/east-stock-quote/">EAST</a>) shares are sliding over 21% despite a lack of news this morning.</li>



<li>Moolec Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock is dropping more than 18% <a href="https://www.stocktitan.net/news/MLEC/moolec-signs-an-offtake-agreement-with-major-global-cpg-company-to-sfqwiqzywbga.html">after signing an offtake agreement</a>.</li>



<li>Lottery.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/ltry-stock-quote/">LTRY</a>) shares are decreasing over 17% on Monday morning.</li>



<li>ProShares Trust ProShares UltraShort Bitcoin ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/sbit-stock-quote/">SBIT</a>) stock is falling more than 16% this morning.</li>



<li>Logistic Properties (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lpa-stock-quote/">LPA</a>) shares are slipping over 15% after <a href="https://www.nasdaq.com/press-release/logistic-properties-americas-expands-board-appointments-two-independent-directors">adding two new directors</a>.</li>



<li>Locafy (NASDAQ:<a href="https://investorplace.com/stock-quotes/lcfy-stock-quote/">LCFY</a>) stock is dipping more than 15% today.</li>



<li>BioNexus Gene Lab (NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) shares close out our pre-market stock movers down over 15% on Monday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!



Moving stocks are new agreements, a patent, a public offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>SILO Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/silo-stock-quote/">SILO</a>) stock is rocketing more than 69% after <a href="https://www.nasdaq.com/press-release/silo-pharma-secures-exclusive-global-license-alzheimers-therapeutic-2024-07-16">securing a new license</a>.</li>



<li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) shares are soaring over 65% with heavy pre-market trading.</li>



<li>SciSparc (NASDAQ:<a href="https://investorplace.com/stock-quotes/sprc-stock-quote/">SPRC</a>) stock is surging more than 39% on a <a href="https://www.nasdaq.com/press-release/scisparc-announces-us-patent-application-treating-metabolic-syndrome-and-weight-loss">new weight loss patent</a>.</li>



<li>Meiwu Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/wnw-stock-quote/">WNW</a>) shares are rising over 30% with strong early morning trading.</li>



<li>Singing Machine (NASDAQ:<a href="https://investorplace.com/stock-quotes/mics-stock-quote/">MICS</a>) stock is increasing more than 25% on a <a href="https://www.nasdaq.com/press-release/singing-machines-subsidiary-semicab-announces-over-9-million-contracted-revenue">$9 million revenue backlog contract</a>.</li>



<li>Passage Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/pasg-stock-quote/">PASG</a>) shares are gaining over 18% on <a href="https://www.nasdaq.com/press-release/passage-bio-announces-positive-feedback-fda-expansion-uplift-d-trial-pbft02-include">clinical trial expansion feedback</a>.</li>



<li>AEON Biopharma (NYSEMKT:<a href="https://investorplace.com/stock-quotes/aeon-stock-quote/">AEON</a>) stock is climbing more than 16% with strong pre-market trading.</li>



<li>Shineco (NASDAQ:<a href="https://investorplace.com/stock-quotes/sisi-stock-quote/">SISI</a>) shares are getting an over 12% boost after <a href="https://www.stocktitan.net/news/SISI/shineco-announces-closing-of-2-million-underwritten-public-r9iot7ulzqfp.html">closing a public offering</a>.</li>



<li>SMX (Security Matters) (NASDAQ:<a href="https://investorplace.com/stock-quotes/smx-stock-quote/">SMX</a>) stock is jumping more than 11% <a href="https://www.nasdaq.com/press-release/smx-announces-effective-date-reverse-stock-split-2024-07-11">following a reverse stock split</a>.</li>



<li>Biomerica (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmra-stock-quote/">BMRA</a>) shares are up over 11% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Autonomix Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/amix-stock-quote/">AMIX</a>) stock is diving more than 18% <a href="https://www.nasdaq.com/press-release/autonomix-enters-definitive-agreement-license-intellectual-property-fda-cleared">following a rally yesterday</a>.</li>



<li>Vince (NYSE:<a href="https://investorplace.com/stock-quotes/vnce-stock-quote/">VNCE</a>) shares are tumbling over 17% without any clear news this morning.</li>



<li>TuanChe (NASDAQ:<a href="https://investorplace.com/stock-quotes/tc-stock-quote/">TC</a>) stock is taking a more than 17% beating on Tuesday morning.</li>



<li>Greenpro Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) shares are sliding over 17% after <a href="https://www.nasdaq.com/press-release/greenpro-capital-corp-and-green-x-corp-forms-strategic-alliance-bank-islam-trust">rising yesterday on a strategic alliance</a>.</li>



<li>Lottery.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/ltry-stock-quote/">LTRY</a>) stock is dropping more than 16% on Tuesday.</li>



<li>Vicinity Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/vev-stock-quote/">VEV</a>) shares are decreasing over 16% this morning.</li>



<li>Tantech (NASDAQ:<a href="https://investorplace.com/stock-quotes/tanh-stock-quote/">TANH</a>) stock is falling more than 15% despite a lack of news this morning.</li>



<li>MF International (NASDAQ:<a href="https://investorplace.com/stock-quotes/mfi-stock-quote/">MFI</a>) shares are slipping over 14% on Tuesday morning.</li>



<li>Cyngn (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/">CYN</a>) stock is dropping close to 14% <a href="https://www.benzinga.com/news/24/07/39781479/cyngn-shares-were-up-by-more-than-50-whats-going-on">after a recent rally</a>.</li>



<li>Lixiang Education (NASDAQ:<a href="https://investorplace.com/stock-quotes/lxeh-stock-quote/">LXEH</a>) shares close out our pre-market stock movers down more than 12% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-16th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Lottery.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/ltry-stock-quote/">LTRY</a>) just reported results for the second quarter of 2024.<ul><li>Lottery.com reported earnings per share of -$1.47.</li><li>The company reported revenue of $256,997.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ltry-stock-earnings-lottery-com-for-q2-of-2024/">LTRY Stock Earnings: Lottery.com Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

LTRY Stock Earnings: Lottery.com Reported Results for Q2 2024

Lottery.com files to sell 50M shares of common stock

Lottery.com auditors flag concerns regarding co's ability to continue as going concern

Lottery.com gets Nasdaq notice for non-compliance

New insider activity at Lottery.com, Inc. ( ($LTRY) ) has taken place on February 7, 2025. Director Matthew Howard McGahan has sold 115,000 shares ...

Director Makes a Major Move with Lottery.com Stock Sale

AEON

AMIX

BGLC

BITU

BMRA

BTFX

CGBS

CPOP

EAST

ETHT

GPAK

GRNQ

LCFY

LTRY

LTRYW

LXEH

MICS

MLEC

PASG

PETZ

PHUN

QLGN

SBIT

SILO

SISI

SPRC

TANH

VNCE

Press Releases

Lottery.com Finalizes Acquisition of S&MI Ltd

Lottery.com Finalizes Agreement Terms for S&MI Ltd Acquisition

Lottery.com Completes Acquisition of S&MI Ltd, Rebranding as Sports.com Media Ltd

Sports.com Expands Geographical Footprint, Launching in New Markets Across Asia

Lottery.Com Signs MOU to Acquire CMF Media (CMF) to Facilitate Sports.Com's Production of Original Content

Sports.com Accelerates Global Expansion Through Key Partnerships and Unveils an Expanded Sports Content Platform

Markets

Lottery.com Inc. Outlines Future Growth Plans Following Registration Statement on Form S-1 Effectiveness

Lottery.com Inc. Chairman Addresses Effective Form S-1 Registration Statement

Lottery.com Inc. Receives Expected Notice from The NASDAQ Stock Market LLC Pertaining to its Form 10-Q of September 30, 2024

Lottery.com Inc. Announces Launch of International Lottery Operations

Accel Entertainment

PlayAGS

Ballys

Codere Online Luxembourg, S.A. - Ordinary Shares

Codere Online Luxembourg

Century Casinos

Canterbury Park Holding Corporation - Common Stock

Canterbury Park Holding

Full House Resorts

Golden Entertainment, Inc. - Common Stock

Golden Entertainment

Inspired Entertainment, Inc. - Common Stock

Inspired Entertainment

Studio City International Holdings Limited American depositary shares, each representing four Class A ordinary shares

Studio City Intl Hldgs

High Roller Technologies, Inc. Common Stock

High Roller Technologies

SharpLink Gaming

Comments

Lottery.com

뉴스

에 대한 최신 뉴스 Lottery.com (NASDAQ:LTRY) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌